1. Home
  2. TRMD vs WVE Comparison

TRMD vs WVE Comparison

Compare TRMD & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRMD
  • WVE
  • Stock Information
  • Founded
  • TRMD 1889
  • WVE 2012
  • Country
  • TRMD United Kingdom
  • WVE Singapore
  • Employees
  • TRMD N/A
  • WVE N/A
  • Industry
  • TRMD Marine Transportation
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRMD Consumer Discretionary
  • WVE Health Care
  • Exchange
  • TRMD Nasdaq
  • WVE Nasdaq
  • Market Cap
  • TRMD 1.9B
  • WVE 2.1B
  • IPO Year
  • TRMD N/A
  • WVE 2015
  • Fundamental
  • Price
  • TRMD $20.39
  • WVE $10.99
  • Analyst Decision
  • TRMD Buy
  • WVE Strong Buy
  • Analyst Count
  • TRMD 1
  • WVE 10
  • Target Price
  • TRMD $48.00
  • WVE $21.60
  • AVG Volume (30 Days)
  • TRMD 1.4M
  • WVE 1.0M
  • Earning Date
  • TRMD 03-06-2025
  • WVE 03-05-2025
  • Dividend Yield
  • TRMD 23.54%
  • WVE N/A
  • EPS Growth
  • TRMD N/A
  • WVE N/A
  • EPS
  • TRMD 7.70
  • WVE N/A
  • Revenue
  • TRMD $1,641,593,000.00
  • WVE $53,610,000.00
  • Revenue This Year
  • TRMD N/A
  • WVE N/A
  • Revenue Next Year
  • TRMD N/A
  • WVE $48.58
  • P/E Ratio
  • TRMD $2.77
  • WVE N/A
  • Revenue Growth
  • TRMD 3.90
  • WVE N/A
  • 52 Week Low
  • TRMD $17.77
  • WVE $3.50
  • 52 Week High
  • TRMD $40.47
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • TRMD 46.59
  • WVE 34.06
  • Support Level
  • TRMD $20.53
  • WVE $10.57
  • Resistance Level
  • TRMD $23.20
  • WVE $12.03
  • Average True Range (ATR)
  • TRMD 0.70
  • WVE 0.69
  • MACD
  • TRMD 0.24
  • WVE -0.17
  • Stochastic Oscillator
  • TRMD 35.25
  • WVE 12.54

About TRMD TORM plc

TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Exhaust segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: